Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000790686 | SCV000331268 | pathogenic | not provided | 2013-02-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000264401 | SCV000818558 | pathogenic | Severe X-linked myotubular myopathy | 2022-06-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individuals with X-linked myotubular myopathy (PMID: 9305655, 20358311). This variant is also known as c.124C>T. ClinVar contains an entry for this variant (Variation ID: 92678). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg24*) in the MTM1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MTM1 are known to be pathogenic (PMID: 9305655, 10063835). |
Genetic Services Laboratory, |
RCV000790686 | SCV002069150 | pathogenic | not provided | 2018-03-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000790686 | SCV005201744 | pathogenic | not provided | 2023-12-17 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 34011573, 29687370, 9305655, 15725586, 12522554, 10790201, 20358311) |